Lisinopril

Safety Summary

Regulatory Status

Sources

These citations are the ones recorded for the human adult context.

• FDA Prescribing Information: Lisinopril (Prinivil/Zestril) — ACE inhibitor; Black Box angioedema + pregnancy; cough; renal artery stenosis; hyperkalemia; pediatric hypertension ≥6yr; CKD proteinuria; Black Americans risk; WHO Essential Medicine (2023) REGULATORY · 2023
• ASPCA Animal Poison Control Center: Cardiac Drug Toxicosis in Pets — statin myopathy in cats; beta-blocker bradycardia dogs; CCB toxicity (amlodipine/diltiazem); ACE inhibitor renal effects; warfarin anticoagulant; furosemide; toxic dose thresholds (2023) VETERINARY · 2023
• Permissible Exposure Limits – OSHA Annotated Table Z-1 REGULATORY
• D-901 AC1 part BCD capture: 2026-09-27-d901-partBCD-comptox-cas-hq-c-org-000354 DATABASE
• OEHHA Proposition 65 List of Carcinogens or Reproductive Toxicants (CSV, list date 31-Jul-26) REGULATORY
• EPA CompTox CTX API: predicted properties for DTXSID2045600 (Lisinopril) REFERENCE

Same data as the API response, which is open and needs no key. The full per-record source list is available to authenticated callers.